Subtopic Deep Dive
Autosomal Dominant Polycystic Kidney Disease
Research Guide
What is Autosomal Dominant Polycystic Kidney Disease?
Autosomal Dominant Polycystic Kidney Disease (ADPKD) is a hereditary disorder caused by mutations in PKD1 or PKD2 genes leading to fluid-filled cysts in the kidneys and progression to end-stage renal disease.
ADPKD represents the most common inherited kidney disease, affecting 1 in 1,000 individuals. Mutations in PKD1 account for 85% of cases with more severe outcomes compared to PKD2 (Igarashi and Somlo, 2002; 595 citations). Disease severity correlates with polycystin-1 dosage (Hopp et al., 2012; 432 citations). Over 20 papers from 2002-2018 detail cystogenesis and ciliary signaling mechanisms.
Why It Matters
ADPKD drives 10% of end-stage renal disease cases worldwide, necessitating therapies to slow cyst growth. Vasopressin receptor antagonists like tolvaptan target cAMP signaling implicated in cyst expansion (Harris and Torres, 2014). mTOR inhibitors address polycystin dysfunction in cystogenesis (Igarashi and Somlo, 2002). Polycystin-2 calcium channel defects link to hypertension via nitric oxide pathways (AbouAlaiwi et al., 2009), informing cardiovascular management.
Key Research Challenges
Variable Disease Severity
PKD1 hypomorphic alleles cause milder phenotypes than null mutations, complicating prognosis (Hopp et al., 2012). Dosage effects require precise genetic modeling (Lantinga-van Leeuwen et al., 2004). Over 400 citations highlight inconsistent cyst kinetics post-Pkd1 loss (Piontek et al., 2007).
Cystogenesis Mechanisms
Primary cilia sense mechanical stimuli via polycystin complexes, but channel kinetics remain unclear (Köttgen et al., 2008; 394 citations). Developmental switches dictate cyst formation timing after Pkd1 inactivation (Piontek et al., 2007). Polycystin-1 cleavage disruptions by mutations impair signaling (Qian et al., 2002).
Therapeutic Target Validation
Genetic modifiers explain phenotypic variability, hindering drug targeting (Harris and Torres, 2014; 326 citations). Ciliary calcium signaling via TRPP2 influences nitric oxide cascades relevant to hypertension (AbouAlaiwi et al., 2009). Lowering Pkd1 expression alone induces cysts, questioning full knockout models (Lantinga-van Leeuwen et al., 2004).
Essential Papers
Ciliopathies: an expanding disease spectrum
Aoife Waters, Philip L. Beales · 2011 · Pediatric Nephrology · 688 citations
Genetics and Pathogenesis of Polycystic Kidney Disease
Peter Igarashi, Stefan Somlo · 2002 · Journal of the American Society of Nephrology · 595 citations
Polycystic kidney disease (PKD), a common genetic cause of chronic renal failure in children and adults, is characterized by the accumulation of fluid-filled cysts in the kidney and other organs. T...
Signaling through the Primary Cilium
Gabrielle Wheway, Liliya Nazlamova, John T. Hancock · 2018 · Frontiers in Cell and Developmental Biology · 506 citations
The presence of single, non-motile "primary" cilia on the surface of epithelial cells has been well described since the 1960s. However, for decades these organelles were believed to be vestigial, w...
Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity
Katharina Hopp, Christopher J. Ward, Cynthia J. Hommerding et al. · 2012 · Journal of Clinical Investigation · 432 citations
Autosomal dominant polycystic kidney disease (ADPKD) is caused by mutations to PKD1 or PKD2, triggering progressive cystogenesis and typically leading to end-stage renal disease in midlife. The phe...
A critical developmental switch defines the kinetics of kidney cyst formation after loss of Pkd1
Klaus Piontek, Luís F. Menezes, Miguel A. García-González et al. · 2007 · Nature Medicine · 412 citations
TRPP2 and TRPV4 form a polymodal sensory channel complex
Michael Köttgen, Bjoern Buchholz, Miguel A. García-González et al. · 2008 · The Journal of Cell Biology · 394 citations
The primary cilium has evolved as a multifunctional cellular compartment that decorates most vertebrate cells. Cilia sense mechanical stimuli in various organs, but the molecular mechanisms that co...
Lowering of Pkd1 expression is sufficient to cause polycystic kidney disease
Irma S Lantinga‐van Leeuwen, Johannes G. Dauwerse, Hans J. Baelde et al. · 2004 · Human Molecular Genetics · 350 citations
Autosomal dominant polycystic kidney disease (ADPKD) is a major cause of renal failure and is characterized by the formation of many fluid-filled cysts in the kidneys. It is a systemic disorder tha...
Reading Guide
Foundational Papers
Start with Igarashi and Somlo (2002; 595 citations) for genetics/pathogenesis overview; Hopp et al. (2012; 432 citations) for dosage-severity link; Piontek et al. (2007; 412 citations) for cyst kinetics switch.
Recent Advances
Harris and Torres (2014; 326 citations) on genetic mechanisms/signaling; Wheway et al. (2018; 506 citations) on primary cilium signaling.
Core Methods
Hypomorphic mouse models (Lantinga-van Leeuwen et al., 2004); polycystin cleavage assays (Qian et al., 2002); ciliary calcium imaging (AbouAlaiwi et al., 2009; Köttgen et al., 2008).
How PapersFlow Helps You Research Autosomal Dominant Polycystic Kidney Disease
Discover & Search
Research Agent uses searchPapers and citationGraph to map PKD1/PKD2 mutation networks from 250M+ OpenAlex papers, starting with Hopp et al. (2012) as a hub (432 citations). exaSearch uncovers ciliopathy overlaps, while findSimilarPapers reveals dosage effect studies like Lantinga-van Leeuwen et al. (2004).
Analyze & Verify
Analysis Agent applies readPaperContent to extract cystogenesis models from Igarashi and Somlo (2002), then verifyResponse with CoVe checks mutation impacts against abstracts. runPythonAnalysis simulates Pkd1 dosage curves using NumPy/pandas on expression data; GRADE grades evidence for vasopressin antagonists (A: high from Harris and Torres, 2014).
Synthesize & Write
Synthesis Agent detects gaps in polycystin-1 cleavage research post-Qian et al. (2002), flags contradictions in ciliary signaling (Wheway et al., 2018 vs. Köttgen et al., 2008). Writing Agent uses latexEditText for cystogenesis pathway edits, latexSyncCitations for 10+ papers, latexCompile for figures, and exportMermaid for polycystin-TRPV4 channel diagrams.
Use Cases
"Model Pkd1 dosage effects on cyst severity from mouse data."
Research Agent → searchPapers('Pkd1 dosage polycystic') → Analysis Agent → runPythonAnalysis (pandas plot Hopp et al. 2012 expression vs. cyst volume) → matplotlib cyst kinetics graph.
"Draft LaTeX review on PKD1 mutations and therapeutics."
Synthesis Agent → gap detection (Harris and Torres 2014) → Writing Agent → latexEditText (add vasopressin section) → latexSyncCitations (10 papers) → latexCompile → PDF with cystogenesis figure.
"Find GitHub code for polycystin calcium channel simulations."
Research Agent → paperExtractUrls (AbouAlaiwi et al. 2009) → paperFindGithubRepo → githubRepoInspect → runPythonAnalysis (validate NO signaling model code).
Automated Workflows
Deep Research workflow conducts systematic review of 50+ ADPKD papers: searchPapers → citationGraph (PKD1 hub) → DeepScan 7-steps with CoVe checkpoints on cystogenesis claims. Theorizer generates hypotheses on polycystin dosage modifiers from Igarashi/Somlo (2002) + recent genetics. DeepScan verifies ciliary mechanosensing via readPaperContent + statistical Python analysis.
Frequently Asked Questions
What defines ADPKD?
ADPKD arises from dominant PKD1 (85%) or PKD2 mutations causing renal cysts and end-stage disease by midlife (Hopp et al., 2012).
What are key methods in ADPKD research?
Mouse models show Pkd1 dosage governs severity (Lantinga-van Leeuwen et al., 2004); ciliary calcium imaging reveals TRPP2 mechanosensitivity (Köttgen et al., 2008).
What are seminal papers?
Igarashi and Somlo (2002; 595 citations) detail genetics/pathogenesis; Hopp et al. (2012; 432 citations) link polycystin-1 dosage to severity.
What open problems exist?
Phenotypic modifiers unexplained (Harris and Torres, 2014); precise cyst initiation kinetics post-Pkd1 loss (Piontek et al., 2007).
Research Genetic and Kidney Cyst Diseases with AI
PapersFlow provides specialized AI tools for Biochemistry, Genetics and Molecular Biology researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Paper Summarizer
Get structured summaries of any paper in seconds
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
See how researchers in Life Sciences use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Autosomal Dominant Polycystic Kidney Disease with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Biochemistry, Genetics and Molecular Biology researchers
Part of the Genetic and Kidney Cyst Diseases Research Guide